List of Genetic Analysis/Screening Companies in Texas - 11

Aranscia unlocks the power of precision medicine by serving the needs of clinical professionals directly within the care workflow.

ARQGenetics offers custom-designed gene panels to provide accurate real-time gene expression data.

Baylor Genetics offers a full spectrum of cost-effective, genetics testing and provides clinically relevant solutions. They offer whole exome sequencing, prenatal diagnostics, cytogenetics, molecular diagnostics, oncology, chromosomal microarray analysis, and over 30 enzyme assays. Along with these tests come interpretation services.

The science of genetics. The business of discovery. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity's duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

MAVEvidence is the premier functional evidence resource for the clinical genetics community. MAVEvidence delivers increased productivity and time savings through comprehensive curation, rigorous analysis, and clear presentation of functional evidence derived from high-throughput studies of genetic variants. The MAVEvidence platform contains more than 187,000 pieces of evidence across 125,000 genetic variants, and is continually updated with data from the latest functional studies.

Erisyon is transforming the field of proteomics with the world's first single molecule protein sequencer. With unprecedented sensitivity and scalability for proteomics, Erisyon enables new applications across the Life Sciences Erisyon has emerged from the University of Texas at Austin to commercialize the world's first single molecule protein sequencer. Inheriting work developed over the course of the past decade at UT's Center for Systems and Synthetic Biology, Erisyon was founded by a group of technologists and entrepreneurs with the ambition to usher in new discoveries that make the world healthier, safer, and more abundant.

Form empowers scientists to harness the data, computing power and collaboration that drive how today's breakthroughs are made.

Hera Biotech is developing and commercializing a non-surgical test for endometriosis diagnosis and staging.

LC Sciences is a global biotechnology company providing products and services to genomics and proteomics researchers across an array of markets for nucleic acid/protein analysis, biomarker-discovery and drug development. Our innovative products and comprehensive services are based on several unique, core technology platforms developed by the scientists here at LC Sciences. A wide range of microarray service products are based on our µParaflo® microfluidic on-chip synthesis technology. This technology enables us to provide unique and customizable arrays of oligonucleotides, peptides, and their analog molecules. Our line of microarray services includes microRNA profiling, custom oligonucleotide (aptamer) screening, and peptide arrays for epitope mapping, protein kinase substrate profiling, and phosphopeptide binding assays. The OligoMix® technology has significantly reduced the cost and increased the speed of highly multiplexing genome-scale experiments such as exploration of small RNAs and designer gene/DNA library synthesis. OligoMix® technology has been applied to library construction of various biomolecules, sequence capture for targeted next-gen sequencing, and synthetic biology. The recently developed OligoFix™ strategy for error correction of microarray synthesized oligos has greatly improved the utility of OligoMix® for synthetic biology applications. The game-changing VariantPro™ multiplex-PCR based targeted sequencing system provides a simple, robust process delivering cost savings due to improved sequencing efficiency. Unlike singleplex methods with limited scalability and inflexible or traditional multiplex methods that suffer from primer induced variation in coverage requiring additional sequencing depth, VariantPro™ combines the specificity of a singleplex PCR reaction with the scalability of a multiplex reaction into a single step via relay-PCR, requiring less sequencing depth per sample.

MicroGenDX provides qPCR+NGS sequencing for the detection of infectious diseases. The American Medical Association (AMA) and Medicare have issued a billing code to MicroGenDX to provide this testing service, recognizing this technology as medically necessary. MicroGenDX is trusted by over 39,000 physicians worldwide and has helped over 900,000 patients with diagnostic testing for their chronic and life-threatening infections. MicroGenDX is a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvements Amendments (CLIA) licensed clinical laboratory. Tens of thousands of patients with chronic and often life-threatening infections have benefited from MicroGenDX's work. MicroGenDX's NGS technology offers several advantages over traditional culture-based methods for identifying microorganisms. It can detect a wider range of microorganisms, including those that are difficult to culture or grow in a laboratory. It also provides more accurate and comprehensive results, as it can detect multiple microorganisms in a single sample and identify them at the species or strain level. Additionally, NGS technology is faster than traditional methods, allowing for quicker diagnosis and treatment decisions.  MicroGenDX's testing services are used in a variety of settings, including hospitals, long-term care facilities, dental offices, and veterinary clinics. Their technology has been applied to a wide range of clinical conditions, including chronic wounds, orthopedic infections, respiratory infections, and urinary tract infections, among others.

Signature Science's consultants serve government and commercial clients through a wide array of technical offerings. We combine scientific rigor with proven quality assurance processes to deliver solution-focused, well-executed projects and contracts. Our expertise enhances the credibility and defensibility of government programs that provide for our national and homeland security. The knowledge and experience of our consultants span a wide array of disciplines that match the technical needs of clients and the management requirements of our business. We have credentials in chemistry, biology, microbiology, biochemistry, forensic science, statistics, data science, quality assurance, engineering, physics, and management.